Evidence map›Paper›PMID 41369477›Full record

ArticleNanomaterials (Basel, Switzerland)2025

Unveiling the Unique Reinforcement Mechanisms of Coiled Carbon Nanotubes and Their Hydrogenated Counterparts in Asphalt Modification.

Fenghua Nie, Hang Lin, Xing Su, Ke Ou, Yifan Chen

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fenghua NieSchool of Resources and Safety Engineering, Central South University, Changsha 410083, China.ORCID 0000-0003-2961-7939
Hang LinSchool of Resources and Safety Engineering, Central South University, Changsha 410083, China.ORCID 0000-0002-5924-5163
Xing SuSchool of Resources and Safety Engineering, Central South University, Changsha 410083, China.
Ke OuChina Railway No.5 Engineering Group Co., Ltd., Guiyang 550000, China.
Yifan ChenSchool of Resources and Safety Engineering, Central South University, Changsha 410083, China.

Funding

Guizhou Provincial Major Scientific and Technological Program 2023-425
6 · The paper itself

Abstract

Coiled carbon nanotubes (CCNTs) and hydrogenated coiled carbon nanotubes (HCCNTs) are advanced nanomaterials recognized as having exceptional mechanical properties and the potential to enhance composite materials. This study examines the pullout performance of CCNTs and HCCNTs in reinforcing asphalt nanocomposites through molecular dynamics simulations. Results indicate that CCNTs generally exhibit superior maximum pullout forces compared to HCCNTs, particularly at lower temperatures, suggesting stronger adhesion within the asphalt matrix. Conversely, HCCNTs demonstrate enhanced stability and flexibility under varying temperature conditions, allowing them to maintain more pullout energy over longer distances. Molecular movement analyses reveal that CCNTs facilitate greater displacement of asphalt molecules, indicating stronger interactions, while spatial configuration studies show that CCNTs attract more asphalt molecules in close proximity, enhancing their effectiveness. Additionally, HCCNTs possess a larger free volume, which may increase the risk of nano-damage but also allows for greater flexibility during the pullout process. This research highlights the distinct roles of CCNTs and HCCNTs in improving asphalt's mechanical properties, ultimately contributing to the development of more resilient and sustainable asphalt pavements.

Indexed as

asphalthydrogenated coiled carbon nanotubesmolecular dynamics simulationsnanocompositespullout performance

Identifiers

PMID41369477
PMCPMC12692932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.